RxDoctor Payments Data

Marc Brown, MD

MOHS-Micrographic Surgery · Rochester, NYNPI 1508893165

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,380 of the $10,675 with a category attached, or 97.2%. 4 manufacturers reported payments, led by LEO Pharma AS at 52.8% of the total. Reporting peaked in 2021 at $5,640 and has fallen 97.5% since, to $143 in 2025.

$10,675in general payments, 2019–2025

Across 8 payments — averaging $1334.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LEO Pharma AS$6K
  • Regeneron Healthcare Solutions, Inc.$5K
  • Strata Skin Sciences, Inc.$152
  • Integra Lifesciences Corporation$22

What the payments were for

  • Consulting fees$10,38097%
  • Food & beverage$2953%

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
LEO Pharma AS1$5,640
Regeneron Healthcare Solutions, Inc.3$4,861
Strata Skin Sciences, Inc.3$152
Integra Lifesciences Corporation1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,675 in reported general payments places this provider in the 80th percentile of 75 mohs-micrographic surgery providers in New York.

See all mohs-micrographic surgery providers in New York

Medicare billing

Part B allowed, 2024
$200,973
Medicare patients
309
Services billed
951

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other mohs-micrographic surgery in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →